CredibleMeds Mobile is a specialized medical reference app for iOS and Android that provides categorized safety data on medications affecting the QT interval.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Medical
Sentiment
4.3
160 reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
Clinicians and patients use the app to verify drug safety during consultations, replacing manual cross-referencing with a portable, offline-capable database.
For Healthcare professionals, research scientists, and patients with Congenital Long QT Syndrome requiring verified medication safety data.
What does it look like?
Key features
Categorized database of medications that prolong the QT interval or cause TdP arrhythmia. Revenue Link: Category authority and scientific rigor — B2B/partnership hook for hospital electronic prescribing systems.
Dedicated list of contraindicated medications for patients with Congenital Long QT Syndrome. Revenue Link: Specialized clinical safety data — brand barrier that reinforces the app as a critical medical utility.
Local access to drug safety data without requiring an active internet connection. Revenue Link: Retention lever — ensures utility for healthcare professionals in clinical environments with limited connectivity.
How much does it cost?
The app operates as a free, non-profit resource, with monetization occurring via commercial licensing of the underlying QTdrugs technology to hospital systems and software developers.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
CredibleMeds Mobile is currently in a maintenance phase, with the latest release occurring 312 days ago. The development trend shows significant stagnation, as the app has not received a feature update in nearly a year. The most recent activity was limited to minor bug fixes and the addition of offline search functionality. Given the lack of updates over the last 10 months, the app is effectively in a long-term maintenance state.
Who built it?
User Sentiment
What do users think recently?
Recent user voice shows an excited sentiment. Users appreciate mobile access to specialized medical databases provides life-saving information for patients managing complex heart conditions and physicians and medical professionals rely on the database to quickly cross-reference drug safety for patients.
How are ratings & reviews evolving?
What users say, by theme
- Mobile access to specialized medical databases provides life-saving information for patients managing complex heart conditions
- Physicians and medical professionals rely on the database to quickly cross-reference drug safety for patients
- Offline search functionality introduced in the latest update improves reliability for users in clinical settings
- Removal of intuitive search functionality forces users to scroll through long lists to find medications
36 of 36 recent reviews analyzed · high confidence · Excited overall
Read the full review analysisUnlock 2 more frustration themes and 2 user requests, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for CredibleMeds Mobile
How's the Medical market?
CredibleMeds Mobile maintains a specialized position in the Medical category, supported by a 4.4 rating on Android and a 3.7 rating on iOS. The disparity in ratings across platforms suggests that the latest UI changes, particularly the removal of the search bar, have impacted the iOS user experience more acutely.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for CredibleMeds Mobile
Where is it heading?
The market for clinical reference tools is shifting toward high-speed, intuitive interfaces that minimize cognitive load for busy practitioners. CredibleMeds Mobile's current maintenance-mode cadence and recent navigation regressions leave it exposed to more agile, free-to-use medical databases that prioritize user experience over subscription-based monetization.
- Removal of direct search functionality increases lookup time for clinicians, which erodes the app's value as a quick-reference tool in clinical settings.
- Transition to subscription-based access is driving negative sentiment among legacy users, which threatens the app's adoption rate among medical professionals.
The SWOT
- Scientific authority of QTdrugs database functions as a B2B distribution barrier
- Offline-first architecture ensures utility in clinical environments with limited connectivity
- Localized drug databases for international regions could expand the addressable user base
Next best moves
Restore direct search bar because it is the top-requested navigation fix → reduce user frustration
+ 1 more prioritized moveThe counter-intuitive read
The app's shift to subscription models is a…
Read the full takeSince the last report: The app's outlook has shifted from stable to mixed due to mounting user friction regarding subscription-based access and navigation regressions. The introduction of platform-specific rating data reveals that iOS users are experiencing the recent UI changes more negatively than Android users.
Bottom line
Restoring the search functionality would address the primary navigation friction currently eroding the app's utility for clinicians. Prioritizing this fix over monetization experiments will defend the app's position as a critical medical reference tool.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
Report last updated